Format

Send to

Choose Destination
FEBS Lett. 2008 Jan 23;582(2):267-72. Epub 2007 Dec 18.

Melanoma cell sensitivity to Docetaxel-induced apoptosis is determined by class III beta-tubulin levels.

Author information

1
Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan.

Abstract

We have previously shown that Docetaxel-induced variable degrees of apoptosis in melanoma. In this report, we studied the beta-tubulin repertoire of melanoma cell lines and show that class III beta-tubulin expression correlated with Docetaxel-resistance. Sensitive cells showed low levels of class III beta-tubulin with little microtubular incorporation, whereas class III beta-tubulin expression was higher in resistant cells and was incorporated into the cytoskeleton. As proof of concept, abrogation of class III by siRNA reverted Docetaxel-resistant cells to a sensitive phenotype, restoring the microtubular polymerisation response and promoting high levels of apoptosis through Bax activation. These results suggest that phenotypic expression of beta-tubulin class III in melanoma may help identify patients with melanoma that can respond to taxanes.

PMID:
18086570
DOI:
10.1016/j.febslet.2007.12.014
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center